Publication Name	World Journal of Meta-Analysis
Manuscript ID	56768
Country	Italy

Received	2020-05-18 18:13
Peer-Review Started	2020-05-18 18:13
To Make the First Decision
Return for Revision	2020-06-08 07:33
Revised	2020-06-08 15:38
Second Decision	2020-06-28 10:23
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2020-06-28 23:12
Articles in Press	2020-06-28 23:12
Publication Fee Transferred
Edit the Manuscript by Language Editor	2020-06-29 21:15
Typeset the Manuscript	2020-07-06 01:39
Publish the Manuscript Online	2020-07-07 11:53

ISSN	2308-3840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Field of Vision
Article Title	COVID-19: Off-label therapies based on mechanism of action while waiting for evidence-based medicine recommendations
Manuscript Source	Invited Manuscript
All Author List	Matteo Scotto Di Vetta, Marco Morrone and Serafino Fazio
ORCID	Author(s) ORCID Number Matteo Scotto Di Vetta http://orcid.org/0000-0001-7929-8441 Marco Morrone http://orcid.org/0000-0003-3212-9223 Serafino Fazio http://orcid.org/0000-0002-2743-9836
Funding Agency and Grant Number
Corresponding Author	Serafino Fazio, MD, Adjunct Professor, Manager, Department of Internal Medicine, Cardiovascular and Immunologic Sciences, Federico II University of Naples, Via S. Pansini 5, Napoli 80100, Italy. sefazio@libero.it
Key Words	COVID-19; Evidence based medicine; Hydroxycloroquine; Azithromycine; Indomethacine; Doxycycline
Core Tip	The world pandemia due to coronavirus disease 2019 has a high rate of disease trasmission that causes a critical hospitalization overload. Waiting for certainties by evidence based medicine, it is not ethics do not try off-label therapies with some well-known drugs which could have some efficacy based on their mechanisms of action.
Publish Date	2020-07-07 11:53
Citation	Scotto di Vetta M, Morrone M, Fazio S. COVID-19: Off-label therapies based on mechanism of action while waiting for evidence-based medicine recommendations. World J Meta-Anal 2020; 8(3): 173-177
URL	https://www.wjgnet.com/2308-3840/full/v8/i3/173.htm
DOI	https://dx.doi.org/10.13105/wjma.v8.i3.173

Full Article (PDF)	WJMA-8-173.pdf
Full Article (Word)	WJMA-8-173.docx
Manuscript File	56768-Review-Filipodia.docx
Answering Reviewers	56768-Answering reviewers.pdf
Audio Core Tip	56768-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	56768-Conflict-of-interest statement.pdf
Copyright License Agreement	56768-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	56768-Language certificate.pdf
Peer-review Report	56768-Peer-review(s).pdf
Scientific Misconduct Check	56768-Scientific misconduct check.pdf
Scientific Editor Work List	56768-Scientific editor work list.pdf
CrossCheck Report	56768-CrossCheck report.pdf